In agreement with these studies, a recent report has documented that the adoptive transfer of CAR T cells targeting cells expressing EpCAM significantly downmodulated the cancer growth in the xenograft model with high level of safety and no associated toxicity (Zhang et al., 2019). This evidence concerns the gene EPCAM and cancer.